Publications

WHITE PAPER


THE SCIENCE OF EARLIER™: IMPROVING EARLY DETECTION OF ORAL AND OROPHARYNGEAL CANCER


Franzmann E (2018)

Oral Rinse Test as a Diagnostic Aid for Oral Cancer


Franzmann E, Bowden S, Kim M, Ginn G, Bohannon R.


J Clin Oncol. 2016; 34 (suppl; abstr e17509).

Risk Stratification System for Oral Cancer Screening

Pereira LHM, Reis IM, Reategui EP, Gordon C, Saint-Victor S, Duncan R, Gomez C, Bayers S, Fisher P, Perez A, Goodwin WJ, Hu JJ, Franzmann EJ. (2016)

Cancer Prevention Journal. doi: 10.1158/1940-6207.CAPR-15-0200.

Saliva as a Diagnostic Tool


Franzmann EJ. MLO Med Lab Obs.


MLO Med Lab Obs. 2015 Jul;47(7):24-5.

Acceptability of a Rinse Screening Test for Diagnosing Head and Neck Squamous Cell Carcinoma Among Black Americans

Lechner SC, Pereira L, Reategui E, Gordon C, Byrne M, Webb Hooper M, Lee DJ, Abouyared M and Franzmann EJ. Acceptability of a Rinse Screening Test for Diagnosing Head and Neck Squamous Cell Carcinoma Among Black Americans.

Journal of Racial and Ethnic Health Disparities. 2015 Mar;2(1):62-7.

CD44 Interacts with EGFR and Promotes Head and Neck Squamous Cell Carcinoma Initiation and Progression

Perez A, Neskey DM, Wen J, Pereira L, Reategui EP, Goodwin WJ, Carraway KL, Franzmann EJ.

Oral Oncol. 2013;4;49:306-313.

Salivary Markers and Risk Factor Data: A Multivariate Modeling Approach for Head and Neck Squamous Cell Carcinoma Detection

Pereira LHM, Adebisi IN, Perez A, Wiebel M, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB, Franzmann EJ.

Cancer Biomark 2011/2012;10(5):241-9.

Salivary Protein and SolCD44 Levels as a Potential Screening Tool for Early Detection of Head and Neck Squamous Cell Carcinoma

Franzmann EJ, Reategui EP, Pereira LHM, Pedroso F, Joseph D, Allen GO, Hamilton K, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB. (2011)

Head & Neck. doi: 10.1002/hed.21810.

A Comprehensive Analysis of Parotid and Salivary Gland Cancer: Worse Outcomes for Male Gender


Cheung MC, Franzmann E, Sola JE, Pincus DJ, Koniaris LG.


J Surg Res. February 2010.

Molecular Markers of Micrometastasis in Oral Cavity Carcinomas


Germani RM, Civantos FJ, Elgart G, Roberts B, Franzmann EJ.


Otolaryngol Head Neck Surg 141:52-8, 2009.

Unequal Burden of Head and Neck Cancer in the United States


Goodwin WJ, Thomas GR, Parker DF, Joseph D, Levis S, Franzmann E, Anello C, Hu JJ.


Head Neck 30:358-71, 2008.

Characterization of CD44v3-Containing Isoforms in Head and Neck Cancer


Elizabeth J. Franzmann, Erika P. Reategui, Felipe Pedroso, et al.


Cancer Epidemiol Biomarkers Prev July 2007; 16:1348-1355.

Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer


Elizabeth J. Franzmann, Erika P. Reategui, Kermit L. Carraway, et al.


Cancer Epidemiol Biomarkers Prev March 2005; 14:735-739.

A Novel CD44v3 Isoform Is Involved in Head and Neck Squamous Cell Carcinoma Progression


Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon LYW.


Otolaryngol Head Neck Surg 2001; 24:426-32.

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev1